05 October 2009
Pleomorphic adenoma of the nasal cavity
Jacek Skladzien, Pawel Strek, Krzysztof Oles, Maciej Wiatr, Jerzy Tomik, Roman GlowackiAm J Case Rep 2009; 10:161-165 :: ID: 878218
Abstract
Background: Pleomorphic adenomas are the most common non-malignant tumours of the salivary glands. In 2% of cases, a mixed tumour will change into a malignant mixed tumour. The occurrence of pleomorphic adenomas or malignant pleomorphic adenomas in the nasal cavity, especially on the nasal septum, is very rare.
Case Report: In this article, we present two very rare cases of nasal septum pleomorphic adenomas and describe their medical treatment. The fi rst case deals with a pleomorphic adenomas of the nasal septum treated with an endoscope. The second case is a malignant pleomorphic adenoma of the nasal septum, which was removed with lateral rhinotomy approach.
Conclusions: There are no established standards for diagnosing and treating such cases. An endoscopic approach can be used successfully in the treatment of pleomorphic adenomas that develop from the nasal septum. Due to the fact that malignant pleomorphic adenomas have a very unfavourable prognosis, they require more radical treatment. Individualised therapeutic approaches should be emphasised in cases where there are no guidelines for diagnosis and therapy, such as those that are atypically located and unusually severe. In this paper we introduced practical value of pleomorphic adenoma treatment.
Keywords: neoplasms of the nose, mixed tumors, pleomorhic adenoma, malignant pleomorphic adenoma, tumor of the nasal septum
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946886
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945873
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946571
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946543
Most Viewed Current Articles
21 Jun 2024 : Case report
93,107
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,041
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
27,573
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,942
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030